Investment

Synopsis : In November 2018, Cipla had announced that InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business…

Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…

  The Department of Pharmaceuticals (DoP) has come out with a draft policy to catalyse research and development (R&D) and innovation in…

Introduction The Medical Device industry is highly capital intensive with a long gestation period and requires development and induction of new technologies.…